Ozempic stomach paralysis lawsuits claim GLP-1 drugs caused gastroparesis. See why a gastric emptying study matters and find out if you may qualify.

Diabetic gastroparesis affects a substantial proportion of individuals with long-standing type 1 or type 2 diabetes mellitus. Chronic hyperglycaemia leads to autonomic neuropathy, loss of interstitial ...

Differing professional viewpoints, a lack of diagnostic standards, and regulatory roadblocks to new medications are among the factors hindering progress in treating people with gastroparesis, but ...

Patients taking a glucagon-like peptide 1 receptor agonist (GLP-1 RA) experience only a modest delay in gastric emptying of solid foods and no significant delay for liquids compared with those ...

From frequent stomach aches to feeling full after taking three bites of a meal, those living with gastroparesis may experience a significant impact to their quality of life. Since symptoms often mimic ...

Patients with diabetic gastroparesis (DG) experience chronic, challenging symptoms and currently lack effective treatment options. This study examined whether activating Nav1.8-expressing neurons ...

Functional dyspepsia (FD) and gastroparesis (GP) are gastrointestinal disorders often managed as separate conditions. FD is classified as a disorder of gut-brain interaction (DGBI), characterized by ...

The habit of reaching for cold drinks regardless of the season has become part of daily life for many modern people. In ...